For almost 20 years, data regarding the effect of rhythm control therapy for atrial fibrillation (AF) on cardiovascular prognosis in comparison with rate control therapy has not been conclusive. The safety of rhythm control and anticoagulation therapy has generally improved. Recently, it was revealed that a rhythm-control strategy reduced the risk of adverse cardiovascular events than usual rate control in patients with recent AF (diagnosed within 1 year). Within 1 year after the AF diagnosis, early initiation of rhythm control led to more favorable cardiovascular outcomes than rate control. Early rhythm control reduced the risks of stroke and heart failure-related admission than rate control. Moreover, rhythm control was associated with lower dementia risk than rate control. Finally, early rhythm control treatment was also effective in patients with asymptomatic AF but less effective in older adults. Therefore, in patients with AF, rhythm control should be considered at earlier stages, regardless of symptom.
|Number of pages||17|
|Journal||Korean Circulation Journal|
|Publication status||Published - 2022 Jul|
Bibliographical noteFunding Information:
We express our appreciation to the staff at the “Biological Control Unit/Embrapa Algodão,” especially those responsible for mass rearing the parasitoids and hosts. This research was supported by FINEP and CNPq. We would like to thank the three anonymous referees for valuable comments.
© 2022. The Korean Society of Cardiology
All Science Journal Classification (ASJC) codes
- Internal Medicine
- Cardiology and Cardiovascular Medicine